Two research groups reprogrammed differentiated cells into hematopoietic stem cells (HSCs) using specific culture conditions and retroviral delivery of transcription factors (in red). Dr. Sugimura and colleagues (A) induced pluripotency in human mature cells then redirected their differentiation into HSCs, while Dr. Lis and colleagues (B) directly reprogrammed murine endothelial cells into HSCs.